Health and Happiness May Be Found in a Daily Glass of Wine

Current statistics show UK alcohol consumption to be on the decline, potentially due to its frequently reported association with adverse health consequences. However, it has been suggested that drinking in moderation may also offer protective effects against chronic disease. A recent study by Horst et al. found low-to-moderate and more frequent alcohol consumption to reduce risk of diabetes [1]. After discussing these findings within the literature, focusing on risk of type 2 diabetes, cardiovascular disease and cognitive decline, it could be concluded that following UK alcohol guidelines of drinking no more than 14 units of alcohol per week, but spreading this out across 5-7 occasions and opting for wine more often than beer or spirits, may be appropriate advice for the general population for drinking responsibly and optimising health.

Alcohol is a widely consumed and legal recreational drug, being drunk by 57% of adults in the UK [2]. It is produced by bacterial or yeast fermentation of grains, fruit or vegetables, which yields carbon dioxide and ethanol, the alcohol in standard beverages [3]. The amphiphilic nature of ethanol means it can be passively absorbed across the epithelial membrane in the stomach and small intestine. 10% of this is excreted in breath, sweat and urine [4], but the remainder is transported to the liver for detoxification, primarily via the alcohol dehydrogenase pathway (ADH) converting ethanol to acetaldehyde, and subsequently acetate [5]. However, excessive alcohol intake also induces the microsomal ethanol oxidising system (MEOS).

Alcohol is preferentially metabolised over other fuels due to its ease of conversion to acetyl coA and the absence of hormonal regulation [6], stimulating storage of fats and carbohydrates. However, products of alcohol oxidation also contribute to tissue damage. Acetaldehyde, an intermediary in the process, is highly reactive and toxic, forming adducts by interaction with proteins, lipids and DNA [7], impairing liver function [4]. Moreover, both the ADH pathway and MEOS increase NAD+/NADH ratio, inhibiting the conversion of lactate to pyruvate and malate to oxaloacetate, resulting in lacticacidosis and a lack of precursors for gluconeogenesis [5]. It also reduces fatty acid oxidation, increasing glycerol 3-phosphate availability and enhancing re-esterification to triacylglycerols in the liver by fatty acylcoA transferase [8]. Finally, acetyl coA produced from activation of acetate in skeletal muscle and other extra hepatic tissues is directed towards ketogenesis and fatty acid synthesis due to TCA cycle suppression, further contributing to the pathogenesis of fatty liver disease [9] and hepatic failure.

Despite alcohol consumption being attributed to 5.1% of the overall global burden of disease [10], it has a great social significance, forming part of religious and cultural rituals, and being frequently shared with friends or relatives during a gathering or as part of a meal [11]. Additionally, moderate consumption is one component characterising a Mediterranean diet, a pattern frequently reported to reduce risk of chronic disease. A recently published study by Horst et al. that investigated the association between moderate alcohol consumption and diabetes made the headlines, where it was suggested that ‘drinking a few times a week could reduce diabetes risk’. This review will examine their findings within wider research to determine whether this claim is correct. Moreover, dietary advice should not be given solely focusing on reducing risk of one condition, so the effect of alcohol consumption on risk of cardiovascular disease (CVD) and dementia will also be discussed. This will allow for analysis of whether the current UK recommendations that advocate keeping alcohol consumption to a minimum and drinking no more than 14 units of alcohol per week [12] are appropriate and promote consumption of a quantity of alcohol for potential health optimisation.


Method

Study population

Data from the Danish Health Examination Survey (DANHES) 2007 to 2008 was used in which subjects aged ≥18 years completed self-reported lifestyle, health and morbidity and further information was obtained using the Danish citizen personal identification number.

Alcohol drinking patterns

Lifetime abstainers were those who reported never drinking alcohol and current abstainers were individuals who had not drunk alcohol in the past year. For respondents who had drunk alcohol in the last year, frequency of alcohol consumption and binge drinking were reported. Average daily consumption of wine, beer and spirits was reported in ‘drinks’, where one drink equalled 12g ethanol. Beverage-specific and overall weekly alcohol consumption was calculated. Changes in alcohol consumption over the past 5 years was questioned.

Diabetes incidence data

The Danish National Diabetes Register provided diabetes incidence data but it did not distinguish between type 1 and type 2.

Statistical analysis

Participants were followed from baseline until diabetes diagnosis, emigration, death, or end of study. Median follow up time was 4.9 years. Risk of developing diabetes was estimated using an adjusted Cox proportional hazards regression model. Analyses were conducted separately per sex. Median values of alcohol intake were used as continuous variables to test for a curvilinear association. Lifetime abstainers were excluded from the trend analysis, and from those investigating the frequency of binge drinking and beverage type.

A cubic spline model was used to examine average weekly alcohol amounts, a log likelihood test was performed to test for any interaction between drinking frequency and alcohol amount, and a multivariate analysis excluding BMI was conducted to assess its effect on the results.

Sensitivity analyses were performed, excluding participants who had changed their alcohol consumption within 5 years of baseline, selecting only participants aged 40 years or above at baseline to bias towards type 2 diabetes, and excluding participants diagnosed by criteria 3 and 4 in the Danish National Diabetes Register.


Discussion

Holst et al. found that light to moderate alcohol consumption was associated with lower risk of diabetes compared to abstainers [1]. This study did not differentiate between type 1 and type 2 diabetes (T2D), however the relationship is consistent within the literature findings regarding T2D risk in response to alcohol intake. It has been suggested that moderate alcohol enhances insulin sensitivity [13] and reduces basal insulin secretion [14]. It could be that acetate modulates fat oxidation and suppresses lipolysis [14], reducing release of NEFAs to peripheral tissues, which causes insulin resistance [15]. However, studies in mice showed the increase in insulin sensitivity to be independent of body fat alteration [16], so there is potential for other physiological mechanisms to also exist. An increase in adiponectin in response to alcohol consumption has said to explain 25-30% of the inverse association with T2D risk [17] as adiponectin increases glucose uptake and fat oxidation in muscles [18], the latter of which reduces lipid accumulation and insulin resistance. In addition, there is as much as 45% inhibition of gluconeogenesis in individuals consuming alcohol [16] as a result of the increase in NADH from ethanol metabolism and the effects of adiponectin [19]. Consequently, potential for hyperglycaemia, a major characteristic of T2D, is reduced. Finally, the alcohol associated decrease in fetuin-A level [20], a hepatic glycoprotein involved in the regulation of insulin signalling pathways, may aid in maintaining glucose metabolism to reduce risk of T2D [21].

Although moderate alcohol consumption has been shown to reduce risk of T2D compared to abstention, a U-shaped relationship exists, such that there is also an increased risk of T2D with heavy drinking. Koppes et al. reported a 30% reduced risk for subjects consuming 6-48g alcohol/day compared to both non-consumers and those drinking ≥48g/day [22]. This may be due to the toxic effects of alcohol on pancreatic islet cells, inhibiting insulin secretion [13] and subsequently decreasing tissue glucose uptake. It is important to consider that the non-drinking group may not be homogeneous if it includes ‘never’ and ‘former’ drinkers as ‘former’ drinkers may be likely to have poorer health due to abstention in response to diagnosis of chronic disease [23]. This could result in overestimation in the degree of risk reduction for moderate consumption and the increase in risk for non-consumers and heavy drinkers in comparison. Additionally, weak confounder adjustment may result in the reporting of a greater risk reduction for moderate consumption as moderate drinkers often have several clinical, social and biological characteristics that favour a superior health status [24]. Nonetheless, the physiological plausibility previously discussed suggests that moderate consumption of alcohol may still offer beneficial effects on T2D risk.

Studies considering the association between T2D risk and alcohol consumption suggest a great variation in optimum quantity to consume. Li et al. suggested alcohol at <30g/day to be associated with lower risk of T2D [25], Wei et al. the lowest incidence at 8-17g/day [13] and Carlsson et al. 30% reduced risk at 5-30g/day [26]. A standard drink in the UK is generally considered to contain 12g alcohol, hence this equates to approximately 1-2 drinks/day. However, uncertainties within individual studies and the impact of publication bias on meta-analyses may not allow for absolute recommendations to be made. In particular, there is potential for bias resulting from misclassification of subjects for both exposure and disease due to under-reporting of alcohol intake [26] and its variability over time [27], as well as the frequent use of diabetes self-reporting meaning undiagnosed cases would not be detected [17].

As with the findings by Holst et al. [1], there is vast evidence to suggest that there may be benefits to sex specific guidelines due to differences observed between men and women. In general, the protective effect of alcohol consumption in women occurs at a lower level of intake [25][28], which is likely due to the differences in ethanol metabolism and body composition [29], resulting in higher peak blood alcohol levels in women than men [6]. Nonetheless, it has been suggested that there is a stronger association within women, which may potentially be due to drinking pattern and type of beverage consumed [29]. Most notably, women are frequently wine drinkers. Wine is often reported to offer a greater reduction in risk of T2D [30][31], with Huang  et al. finding a 15% reduced risk from wine consumption but no significant association when considering beer or spirits [32]. Wine contains high quantities of polyphenols. Flavonoid compounds, which have anti-inflammatory and antioxidant properties may enhance insulin sensitivity [33], and non-flavonoid compounds such as resveratrol may improve insulin signalling [34]. Moreover, it has been suggested that red wine may be more favourable than white wine due to its maceration with the skin of the grape resulting in a 10-fold higher polyphenol content [35], and the tannic acid it contains reducing post prandial glucose response [31]. The lack of significant evidence for a similar protective effect for beer consumption could be questioned due to it also being a source of polyphenols [35]. However, it may be that its high carbohydrate content attenuates any risk reduction from such compounds [31].

The alcohol consumption quantities discussed tend to be specified as g/day, as opposed to the traditional guidelines of alcohol intake per week. Holst et al. concluded that more frequent alcohol consumption was associated with lower risk of diabetes independent of amount of alcohol consumed [1], suggesting that 1-2 drinks/day may confer greater health benefits than drinking the same amount of alcohol on fewer occasions. This suggests that the alcohol induced improvement in insulin sensitivity may be transient, potentially only lasting up to 24 hours before returning to baseline [36]. Additionally, chronic alcohol consumption saturates hepatic detoxification enzymes and induces CYP2E1 activity, part of MEOS, resulting in formation of reactive oxygen species, which are implicated in cancer development [37]. Consequently, excessive alcohol consumption should be avoided. The effect observed may, however, be confounded by more frequent alcohol consumers drinking their beverage as part of a meal, which would reduce the rate of alcohol absorption due to the retardation of gastric emptying [6]. Nonetheless, promotion of more frequent consumption may encourage a more healthy relationship with alcohol, reducing the social and economic burden of binge drinking, and potential chronic health effects.

The study by Holst et al. only considered the effect of moderate alcohol consumption on risk of diabetes [1] but recommendations regarding alcohol consumption should not be made based on evidence relating to one chronic disease. However, it is also common for associations between moderate alcohol intake and risk of cardiovascular disease to be reported, partially due to the increase in adiponectin [38], which has anti-inflammatory activity. Further to this, an umbrella shaped association has been observed between alcohol and HDL-cholesterol concentration [39], where moderate alcohol increases HDL cholesterol and hence the removal of lipid deposits in blood vessels, reducing formation of atherosclerotic plaques [35]. A longer lag time to LDL oxidation has also been observed following wine consumption [40], suggesting the beneficial effects of antioxidant polyphenols. These compounds may also contribute to peripheral vasodilation and inhibition of platelet aggregation due to reduced arachidonic acid metabolism and synthesis of thromboxane A2 [41]. Finally, heavy alcohol intake decreases nitric oxide (NO) bioavailability, adversely affecting vascular homeostasis, yet is thought to increase its release from the endothelium [40].

Conversely, alcohol has been hypothesised to enhance progression to neurodegenerative disease [42] as a consequence of damage to brain structure, metabolite toxicity, electrolyte imbalance or thiamine deficiency [43]. Although there are some inconsistencies within the literature [44], there are indications that low and moderate consumption may in fact offer neuroprotective effects, with potential risk reductions of greater than 30% for Alzheimer’s disease and overall dementia [42]. This is thought to be due to its antioxidant content, the interaction with protein kinase C, a cognitive kinase linked to control of memory and learning, and down regulation of nitric synthase, reducing NO and its neurotoxic effects [43]. However, the demographic of greatest interest when considering cognitive decline would be older adults. As lower quantities of alcohol have greater effects in the elderly due to a decrease in body water and lean body mass with age [42] it could be suggested that age specific, as well as sex specific, recommendations may be appropriate to promote alcohol intake within the beneficial range and limit risk of neurotoxic effects.


Impacts

The wider literature has reinforced the results of the study by Holst et al., who observed moderate alcohol consumption to reduce risk of diabetes [1]. Recommendations regarding inclusion of specific foods or nutrients in the diet should not be made if they are likely to have adverse health impacts; focusing solely on reducing risk of one chronic disease may bring another to the forefront. Therefore, the effect on risk of CVD and dementia have also been discussed, finding that moderate alcohol intake may offer similar protective effects. Despite this conclusion, issues arise when defining a ‘moderate’ level due to the great interindividual variation in body composition and metabolic rate.

Both the frequency of drinking and beverage type have been highlighted as important when considering the magnitude of protection observed. The potential transient nature of the physiological effects means it may be of most benefit to spread alcohol consumption throughout the week, consuming a small amount each day. Not only may this offer the greatest health benefits, but it would also reduce the risk of experiencing negative effects from excess consumption such as toxicity, induction of MEOS and symptoms of a hangover. Additionally, wine has been shown to be more protective than spirits and beers due to its antioxidant content, suggesting this beverage should comprise the greatest proportion of alcohol intake.

To conclude, if attempting to generalise the literature findings for the general population it could be said that the current UK guidelines, which advocate drinking up to 14 units of alcohol per week, may be appropriate. This is where 1 unit is equal to approximately 8g of alcohol. It could be of greatest benefit to spread this out over 5-7 days which, in practical terms, equates to no more than one 175ml glass of wine, 1 pint of beer or 50ml spirits per day [45]. However, this should not be taken as absolute recommendations as the large amount of uncertainty and potential for bias within the literature due to the nature of the studies means that protective effects may be observed at lower levels of consumption. It could therefore be said that overall advice should be to drink responsibly, limiting excessive or heavy drinking. Moreover, it seems that drinking an alcoholic beverage with a meal or during a social occasion should not be discouraged as, in addition to the enjoyment it provides, it may have long term health benefits and reduce risk of chronic disease.



[1] Holst, C., Becker, U., Jørgensen, M. E., Grønbæk, M. & Tolstrup, J. S. (2017). Alcohol drinking patterns and risk of diabetes: a cohort study of 70,551 men and women from the general Danish population. Diabetologia.
[2] NHS (2017). Statistics on Alcohol. Surrey: NHS.
[3] Drink Aware. (2017b). Alcohol's ingredients, chemicals and manufacture. URL: https://www.drinkaware.co.uk/alcohol-facts/alcoholic-drinks-units/alcohols-ingredients-chemicals-and-manufacture/
[4] Bullock, C. (1990). The Biochemistry of Alcohol Metabolism - A brief review. Biochemical Education, 18 (2), 62-66.
[5] Kandi, S., Deshpande, N., Rao, P. & Ramana, K. V. (2014). Alcoholism and Its Relation to Hypoglycemia – An Overview. American Journal of Medicine Studies, 2 (3), 46-49.
[6] Cederbaum, A. I. (2012). Alcohol metabolism. Clin Liver Dis, 16 (4), 667-85.
[7] Setshedi, M., Wands, J. R. & de la Monte, S. M. (2010). Acetaldehyde adducts in alcoholic liver disease. Oxidative Medicine and Cellular Longevity, 3 (3), 178-185.
[8] Lieberman, M., Marks, A. D. & Smith, C. (2007). Marks' Essentials of Medical Biochemistry: A clinical approach. Maryland: Lippincott Williams &amp; Wilkins.
[9] Rasineni, K. & Casey, C. A. (2012). Molecular mechanism of alcoholic fatty liver. Indian J Pharmacol, 44 (3), 299-303.
[10] WHO. (2015). Alcohol. URL: http://www.who.int/mediacentre/factsheets/fs349/en/.
[11] Raats, M., de Groot, L. & van Staveren, W. (2009). Food for the ageing population. Cambridge: Woodhead Publishing Limited.
[12] Drink Aware. (2017). Alcohol limits and unit  guidelines. URL: https://www.drinkaware.co.uk/alcohol-facts/alcoholic-drinks-units/alcohol-limits-unit-guidelines/
[13] Wei, M., Gibbons, L. W., Mitchell, T. L., Kampert, J. B. & Blair, S. N. (2000). Alcohol intake and incidence of type 2 diabetes in men. Diabetes Care, 23 (1), 18-22.
[14] Bonnet, F., Disse, E., Laville, M., Mari, A., Hojlund, K., Anderwald, C. H., Piatti, P., Balkau, B. & Grp, R. S. (2012). Moderate alcohol consumption is associated with improved insulin sensitivity, reduced basal insulin secretion rate and lower fasting glucagon concentration in healthy women. Diabetologia, 55 (12), 3228-3237.
[15] Beulens, J. W., Rimm, E. B., Hendriks, H. F. J., Hu, F. B., Manson, J. E. & Mukamal, K. J. (2006). Alcohol consumption and type 2 diabetes: Influence of genetic variation in alcohol dehydrogenase 1C. Circulation, 113 (8), E321-E321.
[16] Hong, J., Smith, R. R., Harvey, A. E. & Nunez, N. P. (2009). Alcohol consumption promotes insulin sensitivity without affecting body fat levels. International Journal of Obesity, 33 (2), 197-203.
[17] Joosten, M. M., Grobbee, D. E., van der A, D. L., Verschuren, W. M. M., Hendriks, H. F. J. & Beulens, J. W. J. (2010). Combined effect of alcohol consumption and lifestyle behaviors on risk of type 2 diabetes. American Journal of Clinical Nutrition, 91 (6), 1777-1783.
[18] Hendriks, H. F. J. (2007). Moderate alcohol consumption and insulin sensitivity: Observations and possible mechanisms. Annals of Epidemiology, 17 (5), S40-S42.
[19] Mathews, M. J., Liebenberg, L. & Mathews, E. H. (2015). The mechanism by which moderate alcohol consumption influences coronary heart disease. Nutrition Journal, 14.
[20] Marques-Vidal, P., Vollenweider, P. & Waeber, G. (2015). Alcohol consumption and incidence of type 2 diabetes. Results from the CoLaus study. Nutrition Metabolism and Cardiovascular Diseases, 25 (1), 75-84.
[21] Ley, S. H., Sun, Q., Jimenez, M. C., Rexrode, K. M., Manson, J. E., Jensen, M. K., Rimm, E. B. & Hu, F. B. (2014). Association between alcohol consumption and plasma fetuin-A and its contribution to incident type 2 diabetes in women. Diabetologia, 57 (1), 93-101.
[22] Koppes, L. L. J., Dekker, J. M., Hendriks, H. F. J., Bouter, L. M. & Heine, R. J. (2005). Moderate alcohol consumption lowers the risk of type 2 diabetes - A meta-analysis of prospective observational studies. Diabetes Care, 28 (3), 719-725.
[23] Knott, C., Bell, S. & Britton, A. (2015). Alcohol Consumption and the Risk of Type 2 Diabetes: A Systematic Review and Dose-Response Meta-analysis of More Than 1.9 Million Individuals From 38 Observational Studies.
[24] Hansel, B., Thomas, F., Pannier, B., Bean, K., Kontush, A., Chapman, M. J., Guize, L. & Bruckert, E. (2010). Relationship between alcohol intake, health and social status and cardiovascular risk factors in the urban Paris-Ile-De-France Cohort: is the cardioprotective action of alcohol a myth? European Journal of Clinical Nutrition, 64 (6), 561-568.
[25] Li, X. H., Yu, F. F., Zhou, Y. H. & He, J. (2016). Association between alcohol consumption and the risk of incident type 2 diabetes: a systematic review and dose-response meta-analysis. American Journal of Clinical Nutrition, 103 (3), 818-829.
[26] Carlsson, S., Hammar, N. & Grill, V. (2005). Alcohol consumption and type 2 diabetes. Diabetologia, 48 (6), 1051-1054
[27] Joosten, M. M., Chiuve, S. E., Mukamal, K. J., Hu, F. B., Hendriks, H. F. J. & Rimm, E. B. (2011). Changes in Alcohol Consumption and Subsequent Risk of Type 2 Diabetes in Men. Diabetes, 60 (1), 74-79.
[28] Baliunas, D. O., Taylor, B. J., Irving, H., Roerecke, M., Patra, J., Mohapatra, S. & Rehm, J. (2009). Alcohol as a Risk Factor for Type 2 Diabetes A systematic review and meta-analysis. Diabetes Care, 32 (11), 2123-2132.
[29] Beulens, J. W. J., van der Schouw, Y. T., Bergmann, M. M., Rohrmann, S., Schulze, M. B., Buijsse, B., Grobbee, D. E., Arriola, L., Cauchi, S., Tormo, M. J., Allen, N. E., van der A, D. L., Balkau, B., Boeing, H., Clavel-Chapelon, F., de Lauzon-Guillan, B., Franks, P., Froguel, P., Gonzales, C., Halkjaer, J., Huerta, J. M., Kaaks, R., Key, T. J., Khaw, K. T., Krogh, V., Molina-Montes, E., Nilsson, P., Overvad, K., Palli, D., Panico, S., Quiros, J. R., Ronaldsson, O., Romieu, I., Romaguera, D., Sacerdote, C., Sanchez, M. J., Spijkerman, A. M. W., Teucher, B., Tjonneland, A., Tumino, R., Sharp, S., Forouhi, N. G., Langenberg, C., Feskens, E. J. M., Riboli, E., Wareham, N. J. & InterAct, C. (2012). Alcohol consumption and risk of type 2 diabetes in European men and women: influence of beverage type and body size The EPIC-InterAct study. Journal of Internal Medicine, 272 (4), 358-370.
[30] Shi, L., Shu, X. O., Li, H. L., Cai, H., Liu, Q. L., Zheng, W., Xiang, Y. B. & Villegas, R. (2013). Physical Activity, Smoking, and Alcohol Consumption in Association with Incidence of Type 2 Diabetes among Middle-Aged and Elderly Chinese Men. Plos One, 8 (11).
[31] Cullmann, M., Hilding, A. & Ostenson, C. G. (2012). Alcohol consumption and risk of pre-diabetes and type 2 diabetes development in a Swedish population. Diabetic Medicine, 29 (4), 441-452.
[32] Huang, J., Wang, X. L. & Zhang, Y. D. (2017a). Specific types of alcoholic beverage consumption and risk of type 2 diabetes: A systematic review and meta-analysis. Journal of Diabetes Investigation, 8 (1), 56-68.
[33] Fagherazzi, G., Vilier, A., Lajous, M., Boutron-Ruault, M. C., Balkau, B., Clavel-Chapelon, F. & Bonnet, F. (2014). Wine consumption throughout life is inversely associated with type 2 diabetes risk, but only in overweight individuals: results from a large female French cohort study. European Journal of Epidemiology, 29 (11), 831-839.
[34] Koloverou, E., Esposito, K., Giugliano, D. & Panagiotakos, D. (2014). The effect of Mediterranean diet on the development of type 2 diabetes mellitus: A meta-analysis of 10 prospective studies and 136,846 participants. Metabolism-Clinical and Experimental, 63 (7), 903-911.
[35] Arranz, S., Chiva-Blanch, G., Valderas-Martinez, P., Medina-Remon, A., Lamuela-Raventos, R. M. & Estruch, R. (2012). Wine, Beer, Alcohol and Polyphenols on Cardiovascular Disease and Cancer. Nutrients, 4 (7), 759-781.
[36] O'Keefe, J. H., Bhatti, S. K., Bajwa, A., DiNicolantonio, J. J. & Lavie, C. J. (2014). Alcohol and Cardiovascular Health: The Dose Makes the Poison . . . or the Remedy. Mayo Clinic Proceedings, 89 (3), 382-393.
[37] Seitz, H. K. & Becker, P. (2007). Alcohol Metabolism and Cancer Risk. Alcohol Res Health, 30 (1), 38-47.
[38] Bell, S. & Britton, A. (2015). The Role of Alcohol Consumption in Regulating Circulating Levels of Adiponectin: A Prospective Cohort Study. Journal of Clinical Endocrinology & Metabolism, 100 (7), 2763-2768.
[39] Huang, S., Li, J. J., Shearer, G. C., Lichtenstein, A. H., Zheng, X. M., Wu, Y. T., Jin, C., Wu, S. L. & Gao, X. A. (2017b). Longitudinal study of alcohol consumption and HDL concentrations: a community-based study. American Journal of Clinical Nutrition, 105 (4), 905-912.
[40] Chiva-Blanch, G., Arranz, S., Lamuela-Raventos, R. M. & Estruch, R. (2013). Effects of Wine, Alcohol and Polyphenols on Cardiovascular Disease Risk Factors: Evidences from Human Studies. Alcohol and Alcoholism, 48 (3), 270-277.
[41] Di Castelnuovo, A., Costanzo, S., Donati, M. B., Iacoviello, L. & de Gaetano, G. (2010). Prevention of cardiovascular risk by moderate alcohol consumption: epidemiologic evidence and plausible mechanisms. Internal and Emergency Medicine, 5 (4), 291-297.
[42] Peters, R., Peters, J., Warner, J., Beckett, N. & Bulpitt, C. (2008). Alcohol, dementia and cognitive decline in the elderly: a systematic review. Age Ageing, 37 (5), 505-12.
[43] Kim, J. W., Lee, D. Y., Lee, B. C., Jung, M. H., Kim, H., Choi, Y. S. & Choi, I. G. (2012). Alcohol and Cognition in the Elderly: A Review. Psychiatry Investigation, 9 (1), 8-16.
[44] Piazza-Gardner, A. K., Gaffud, T. J. B. & Barry, A. E. (2013). The impact of alcohol on Alzheimer's disease: A systematic review. Aging & Mental Health, 17 (2), 133-146.
[45] NHS Choices. (2017). Alcohol units - Live Well - NHS Choices. URL: http://www.nhs.uk/Livewell/alcohol/Pages/alcohol-units.aspx

Comments

Popular posts from this blog

‘Ultra-processed’ foods, the answer to the obesity epidemic or a term to be canned?

Eating Too Much Bacon Could Harm Your Health

'10-a-Day' Keeps CVD Away